AI Article Synopsis

  • The study aimed to compare the transdermal delivery methods of Sinomenine hydrochloride using solid lipid nanoparticles, liposomes, and nanoemulsions.
  • The researchers prepared each formulation using different methods and analyzed their properties, including particle size, encapsulation efficiency, and their impact on skin penetration.
  • Results showed that solid lipid nanoparticles significantly altered the lipid structure of the outer skin layer, allowing for better permeation of the drug compared to the other methods.

Article Abstract

Objective: To investigate the transdermal mechanisms and compare the differences in transdermal delivery of Sinomenine hydrochloride (SN) between solid lipid nanoparticles (SLN), liposomes (LS), and nanoemulsions (NE).

Methods: SN-SLN, SN-LS and SN-NE were prepared by ultrasound, ethanol injection and spontaneous emulsification, respectively. FTIR, DSC, in vitro skin penetration, activation energy (Ea) analysis were used to explore the mechanism of drug penetration across the skin.

Results: The particle size and encapsulation efficiency were 126.60 nm, 43.23 ± 0.48%(w/w) for SN-SLN, 224.90 nm, 78.31 ± 0.75%(w/w) for SN-LS, and 83.22 nm, 89.01 ± 2.16%(w/w) for SN-LS. FTIR and DSC showed the preparations had various levels of impacts on the stratum corneum's lipid structure which was in the order of SLN > NE > LS. Ea values of SN-SLN, SN-LS, and SN-NE crossing the skin were 2.504, 1.161, and 2.510 kcal/mol, respectively.

Conclusion: SLN had a greater degree of alteration on the skin cuticle, which allows SN to permeate skin more effectively.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02652048.2024.2324810DOI Listing

Publication Analysis

Top Keywords

sinomenine hydrochloride
8
sn-sln sn-ls
8
sn-ls sn-ne
8
ftir dsc
8
construction lipid
4
lipid carriers
4
carriers study
4
study transdermal
4
transdermal penetration
4
penetration mechanism
4

Similar Publications

Hydrogel doped with sinomenine-CeO nanoparticles for sustained intra-articular therapy in knee osteoarthritis.

J Drug Target

January 2025

Department of Clinical Laboratory, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.

In this study, we developed an intra-articular injectable hydrogel drug depot (SMN-CeO@G) for sustained OA treatment. This hydrogel system, which carries sinomenine-loaded cerium dioxide nanoparticles (SMN-CeO), enhances anti-inflammatory and anti-apoptotic effects within the joint cavity. SMN-CeO@G features a three-dimensional network structure with an approximate pore size of 10 μm, stably encapsulating SMN-CeO nanoparticles (∼75 nm).

View Article and Find Full Text PDF

Sinomenine modulates the metabolic reprogramming induced by sepsis via CHRNA7.

Life Sci

January 2025

State Key Laboratory of Natural Medicines, School of life science and technology, China Pharmaceutical University, Nanjing 211000, PR China. Electronic address:

Background And Purpose: Sepsis is a condition capable of causing systemic inflammation and metabolic reprogramming. Previous studies have shown that sinomenine (SIN) can mitigate sepsis by reducing inflammation, while the effect on metabolic reprogramming is unclear. The aim of this study is to investigate the function of SIN in metabolic reprogramming in sepsis.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the effects of sinomenine hydrochloride (SH) on colitis induced by DSS in mice, focusing on the Notch signaling pathway.
  • Mice were divided into four groups and assessed for disease activity, mucosal injury, and histopathological changes, revealing that SH significantly alleviated colitis symptoms and reduced inflammation markers.
  • Results indicated that SH treatment lowered the expression of key proteins in the Notch signaling pathway and reduced pro-inflammatory cytokines, suggesting that its therapeutic effect is linked to inhibiting Notch pathway overactivation.
View Article and Find Full Text PDF

Sinomenine (SIN) is a drug for the treatment of rheumatoid arthritis, most of which is administered orally, but it is prone to adverse gastrointestinal effects. Gel can overcome the gastrointestinal adverse effects caused by oral administration. In this paper, a multiscale computational pharmaceutics strategy was developed to guide the systematic study of formulation factors of a SIN gel and, further, to guide the formulation design.

View Article and Find Full Text PDF

Sinomenine (SIN), a bioactive isoquinoline alkaloid extracted from the roots and stems of Sinomenium acutum, is efficacious against various chronic pain conditions. Inhibition of microglial activation at the spinal level contributes to the analgesic effects of SIN. Microglial activation in the spinal dorsal horn is key to sensitising neuropathic pain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!